{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T01:57:10Z","timestamp":1762999030107,"version":"3.44.0"},"reference-count":30,"publisher":"BMJ","issue":"10","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Heart"],"accepted":{"date-parts":[[2014,3,3]]},"published-print":{"date-parts":[[2014,5,15]]},"abstract":"<jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>Studies have shown beneficial effects of cardiac resynchronisation therapy (CRT) on mortality among patients with heart failure. However the incremental benefits in survival from CRT with a defibrillator (CRT-D) are unclear. The choice of appropriate device remains unanswered.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Method<\/jats:title>\n                  <jats:p>This is a single-centre observational study in a tertiary cardiac centre. Patients (n=500) implanted with a CRT device with pacing alone (CRT-P) (n=354) and CRT-D (n=146) were followed for at least 2\u2005years (mean 29\u2005months, SD 14\u2005months). The primary end point was all-cause mortality.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A total of 116 deaths (23.2%) were recorded: 88 (24.8%) and 28 (19.2%), in the CRT-P and CRT-D groups, respectively. At 1\u2005year there was a trend favouring CRT-D (HR 0.54, 95% CI 0.27 to 1.07, p=0.08) but this was attenuated by the 2nd year and became insignificant at the end of follow-up (HR 0.76, 95% CI 0.50 to 1.170, p=0.21). There was no survival benefit from having an internal cardioverter-defibrillator if patients were deemed non-responders to CRT. 27% of the CRT-P patients with ischaemic cardiomyopathy met indications for potential internal cardioverter-defibrillator implantation for primary prevention. These were older patients with poorer baseline function in comparison with CRT-D patients with devices for primary prevention. Once these differences were adjusted for, there was no difference in outcome between the groups.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>CRT-D did not offer additional survival advantage over CRT-P at longer-term follow-up, as the clinical benefit of a defibrillator attenuated with time. Further work is needed to define which subset of patients benefit from CRT-D.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/heartjnl-2014-305537","type":"journal-article","created":{"date-parts":[[2014,4,2]],"date-time":"2014-04-02T00:37:50Z","timestamp":1396399070000},"page":"794-799","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":30,"title":["Cardiac resynchronisation therapy: pacemaker versus internal cardioverter-defibrillator in patients with impaired left ventricular function"],"prefix":"10.1136","volume":"100","author":[{"given":"Khang-Li","family":"Looi","sequence":"first","affiliation":[{"name":"Papworth Hospital NHS Foundation Trust, Cambridge, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parag R","family":"Gajendragadkar","sequence":"additional","affiliation":[{"name":"Papworth Hospital NHS Foundation Trust, Cambridge, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fakhar Z","family":"Khan","sequence":"additional","affiliation":[{"name":"Papworth Hospital NHS Foundation Trust, Cambridge, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maros","family":"Elsik","sequence":"additional","affiliation":[{"name":"Papworth Hospital NHS Foundation Trust, Cambridge, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A","family":"Begley","sequence":"additional","affiliation":[{"name":"Papworth Hospital NHS Foundation Trust, Cambridge, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon P","family":"Fynn","sequence":"additional","affiliation":[{"name":"Papworth Hospital NHS Foundation Trust, Cambridge, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew A","family":"Grace","sequence":"additional","affiliation":[{"name":"Papworth Hospital NHS Foundation Trust, Cambridge, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick M","family":"Heck","sequence":"additional","affiliation":[{"name":"Papworth Hospital NHS Foundation Trust, Cambridge, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Munmohan","family":"Virdee","sequence":"additional","affiliation":[{"name":"Papworth Hospital NHS Foundation Trust, Cambridge, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharad","family":"Agarwal","sequence":"additional","affiliation":[{"name":"Papworth Hospital NHS Foundation Trust, Cambridge, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2014,4,1]]},"reference":[{"key":"2025092001513722000_100.10.794.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(03)01042-8"},{"key":"2025092001513722000_100.10.794.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa032423"},{"key":"2025092001513722000_100.10.794.3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa050496"},{"key":"2025092001513722000_100.10.794.4","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/eht150"},{"key":"2025092001513722000_100.10.794.5","unstructured":"National Institute for Health and Clinical Excellence. NICE technology appraisal guidance 120. Cardiac resynchronisation therapy for the treatment of heart failure. May 2007."},{"key":"2025092001513722000_100.10.794.6","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/eus419"},{"key":"2025092001513722000_100.10.794.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2010.12.091"},{"key":"2025092001513722000_100.10.794.8","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.642892"},{"key":"2025092001513722000_100.10.794.9","doi-asserted-by":"publisher","DOI":"10.2307\/2530299"},{"key":"2025092001513722000_100.10.794.10","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(97)00361-6"},{"key":"2025092001513722000_100.10.794.11","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)04440-2"},{"key":"2025092001513722000_100.10.794.12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa043399"},{"key":"2025092001513722000_100.10.794.13","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.629261"},{"key":"2025092001513722000_100.10.794.14","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.104.520817"},{"key":"2025092001513722000_100.10.794.15","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehl099"},{"key":"2025092001513722000_100.10.794.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2008.08.027"},{"key":"2025092001513722000_100.10.794.17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0906431"},{"key":"2025092001513722000_100.10.794.18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa071098"},{"key":"2025092001513722000_100.10.794.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2012.04.021"},{"key":"2025092001513722000_100.10.794.20","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.113.005146"},{"key":"2025092001513722000_100.10.794.21","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euq328"},{"key":"2025092001513722000_100.10.794.22","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehl438"},{"key":"2025092001513722000_100.10.794.23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.2006.01713.x"},{"key":"2025092001513722000_100.10.794.24","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2009.255"},{"key":"2025092001513722000_100.10.794.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2010.03.042"},{"key":"2025092001513722000_100.10.794.26","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.113.001442"},{"key":"2025092001513722000_100.10.794.27","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3310\/hta11470","article-title":"The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model","volume":"11","author":"Fox","year":"2007","journal-title":"Health Technol Assess"},{"key":"2025092001513722000_100.10.794.28","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2011-000276"},{"key":"2025092001513722000_100.10.794.29","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehs104"},{"key":"2025092001513722000_100.10.794.30","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.910778"}],"container-title":["Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/heartjnl-2014-305537","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T08:51:44Z","timestamp":1758358304000},"score":1,"resource":{"primary":{"URL":"https:\/\/heart.bmj.com\/lookup\/doi\/10.1136\/heartjnl-2014-305537"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,1]]},"references-count":30,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2014,4,16]]},"published-print":{"date-parts":[[2014,5,15]]}},"alternative-id":["10.1136\/heartjnl-2014-305537"],"URL":"https:\/\/doi.org\/10.1136\/heartjnl-2014-305537","relation":{},"ISSN":["1355-6037","1468-201X"],"issn-type":[{"type":"print","value":"1355-6037"},{"type":"electronic","value":"1468-201X"}],"subject":[],"published":{"date-parts":[[2014,4,1]]}}}